1. Home
  2. CELU vs NTZ Comparison

CELU vs NTZ Comparison

Compare CELU & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • NTZ
  • Stock Information
  • Founded
  • CELU 2016
  • NTZ 1959
  • Country
  • CELU United States
  • NTZ Italy
  • Employees
  • CELU N/A
  • NTZ N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • NTZ Home Furnishings
  • Sector
  • CELU Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • CELU 50.4M
  • NTZ 51.8M
  • IPO Year
  • CELU N/A
  • NTZ 1993
  • Fundamental
  • Price
  • CELU $2.30
  • NTZ $4.91
  • Analyst Decision
  • CELU
  • NTZ
  • Analyst Count
  • CELU 0
  • NTZ 0
  • Target Price
  • CELU N/A
  • NTZ N/A
  • AVG Volume (30 Days)
  • CELU 89.6K
  • NTZ 15.4K
  • Earning Date
  • CELU 12-06-2024
  • NTZ 12-12-2024
  • Dividend Yield
  • CELU N/A
  • NTZ N/A
  • EPS Growth
  • CELU N/A
  • NTZ N/A
  • EPS
  • CELU N/A
  • NTZ N/A
  • Revenue
  • CELU $48,200,000.00
  • NTZ $365,846,531.00
  • Revenue This Year
  • CELU N/A
  • NTZ N/A
  • Revenue Next Year
  • CELU $233.89
  • NTZ N/A
  • P/E Ratio
  • CELU N/A
  • NTZ N/A
  • Revenue Growth
  • CELU 225.94
  • NTZ N/A
  • 52 Week Low
  • CELU $1.30
  • NTZ $3.80
  • 52 Week High
  • CELU $7.97
  • NTZ $6.50
  • Technical
  • Relative Strength Index (RSI)
  • CELU 52.94
  • NTZ 56.77
  • Support Level
  • CELU $2.04
  • NTZ $4.63
  • Resistance Level
  • CELU $2.39
  • NTZ $4.93
  • Average True Range (ATR)
  • CELU 0.17
  • NTZ 0.33
  • MACD
  • CELU 0.02
  • NTZ 0.02
  • Stochastic Oscillator
  • CELU 70.76
  • NTZ 92.18

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.

Share on Social Networks: